Benefits of a universal influenza immunization program: more than the reduction in the use of antibiotics.
Glezen
W Paul
WP
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D004363:Drug Utilization; D004636:Emergency Service, Hospital / Q000706:statistics & numerical data*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007251:Influenza, Human / Q000401:mortality / Q000517:prevention & control*; D032541:Mass Vaccination / Q000706:statistics & numerical data*; D009864:Ontario; D011634:Public Health; D014481:United States; D014613:Vaccines, Attenuated; D015164:Vaccines, Inactivated
D000900:Anti-Bacterial Agents; D007252:Influenza Vaccines; D014613:Vaccines, Attenuated; D015164:Vaccines, Inactivated